Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials.
Jamie ShoagYimei LiKelly D GetzYuan-Shung V HuangMatt HallArlene NaranjoTroy RichardsonAmi V DesaiPuja J UmaretiyaRahela Aziz-BoseColleen A KellyDaniel J ZhengHaley M NewmanStacey ZahlerRichard AplencRochelle BagatellKira O BonaPublished in: Pediatric blood & cancer (2024)
Children of Hispanic ethnicity with HRNBL receiving clinical trial-delivered therapy were more likely to experience ICU-level care compared to NHW children. These data suggest that further investigation of treatment-related toxicity as a modifiable mechanism underlying outcome disparities is warranted.
Keyphrases
- clinical trial
- healthcare
- young adults
- palliative care
- stem cells
- randomized controlled trial
- study protocol
- electronic health record
- phase ii
- affordable care act
- social media
- bone marrow
- artificial intelligence
- data analysis
- extracorporeal membrane oxygenation
- newly diagnosed
- cell therapy
- health information
- drug induced